Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00088443
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
183 | 1-((2-HYDROXYETHOXY)METHYL)-5-(3- (BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)- DIONE | A,B,C,D,E,F | 1U1F | 0.71 | |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.74 | |
109 | 2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)- PROPIONIC ACID | A | 1G3C | 0.73 | |
109 | 2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)- PROPIONIC ACID | A | 1G3E | 0.73 | |
MTY | META-TYROSINE | A | 2TOH | 0.75 | |
MTY | META-TYROSINE | A,B | 1BIQ | 0.75 | |
MTY | META-TYROSINE | A | 1Q7O | 0.75 | |
IYG | N-ALPHA-ACETYL-3,5-DIIODOTYROSYLGLYCINE | A | 1OPM | 0.73 | |
GHP | 4-HYDROXYPHENYLGLYCINE | A | 1DSR | 0.74 | |
IFA | A,B | 3FC8 | 0.71 | ||
0E4 | N-acetyl-L-tyrosyl-L-valyl-L-alanyl- L-aspartic acid | B,D | 3GJS | 0.72 | |
TYI | 3,5-DIIODOTYROSINE | A | 2D8W | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | E,I | 1CTP | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A | 2D97 | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A | 2AXE | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A | 2D8O | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A,B | 2VLW | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A,B | 2C3V | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A | 2D98 | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A | 2NOO | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A | 2D8P | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A,B,C,D,E,F, G,H | 3GH8 | 0.7 | |
TYI | 3,5-DIIODOTYROSINE | A,B,C,D | 1L0S | 0.7 | |
099 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)- N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro- 1H-inden-1-yl]butanediamide | A,B | 3HYG | 0.73 | |
TY2 | 3-AMINO-L-TYROSINE | A,B | 2VH3 | 0.72 | |
TY3 | 3-HYDROXY-L-TYROSINE | A,B | 2VH3 | 0.71 | |
BJH | 1(R)-1-ACETAMIDO-2-(3-CARBOXY-2- HYDROXYPHENYL)ETHYL BORONIC ACID | A | 1ERQ | 0.73 | |
098 | (3R)-N~2~-(cyclopropylmethyl)-N~1~- hydroxy-3-(3-hydroxybenzyl)-N~4~- [(1S,2R)-2-hydroxy-2,3-dihydro- 1H-inden-1-yl]-L-aspartamide | A,B | 3HY9 | 0.7 | |
NU1 | 8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN- 4-ONE | A | 4PAX | 0.73 | |
DGH | (2R)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1W7Q | 0.74 | |
DGH | (2R)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H | 1W7R | 0.74 | |
BBB | 1-((2-HYDROXYETHOXY)METHYL)-5-(3- (BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE- 2,4(1H,3H)-DIONE | A,B,C,D,E,F | 1U1G | 0.71 | |
D3P | (2R)-AMINO(3,5-DIHYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1W7Q | 0.72 | |
D3P | (2R)-AMINO(3,5-DIHYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H | 1W7R | 0.72 | |
AEG | 4-[(2R)-2-aminopropyl]phenol | A | 3BUF | 0.71 | |
MTJ | N,O-DIMETHYL-L-TYROSINE | A,B | 1ATL | 0.7 | |
C1N | N-[(BENZYLOXY)CARBONYL]LEUCYL-N~1~- [3-FLUORO-1-(4-HYDROXYBENZYL)-2- OXOPROPYL]LEUCINAMIDE | A | 1ZCM | 0.71 | |
VRV | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO- 4-PHENYL-1,2-DIHYDROPYRIDINE-3- CARBONITRILE | A | 2OBJ | 0.7 | |
RHP | (3R)-3-(PROP-2-YNYLAMINO)INDAN- 5-OL | A,B | 1S3E | 0.73 | |
ZYA | BENZOYL-TYROSINE-ALANINE-METHYL KETONE | A | 1AIM | 0.73 | |
YOF | 3-FLUOROTYROSINE | A,B | 1XIL | 0.72 | |
YOF | 3-FLUOROTYROSINE | A,B | 1XDC | 0.72 | |
YOF | 3-FLUOROTYROSINE | A | 1RRX | 0.72 | |
YOF | 3-FLUOROTYROSINE | A,B | 3FYG | 0.72 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQR | 0.76 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQS | 0.76 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4H | 0.7 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4G | 0.7 | |
TI2 | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.7 | |
GAH | N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}- 3-CYCLOHEXYL-L-ALANYL)AZETIDIN- 2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]- L-LYSINAMIDE | A,H | 1XM1 | 0.71 | |
3XH | 3-Hydroxyhippuric acid | A | 3E9K | 0.77 | |
AZY | 3-AZIDO-L-TYROSINE | A | 2YXN | 0.71 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.76 | |
TYC | L-TYROSINAMIDE | A | 2OCI | 0.76 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.74 | |
NAT | ETHYL 4-(3-HYDROXYPHENYL)-6-METHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE- 5-CARBOXYLATE | A,B | 1Q0B | 0.87 | |
NAT | ETHYL 4-(3-HYDROXYPHENYL)-6-METHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE- 5-CARBOXYLATE | A,B | 1X88 | 0.87 | |
OI1 | 3-(4-HYDROXYBENZYL)-2-[1-({[2-(4- HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]- 4-OXO-3,6,11,11A-TETRAHYDRO-4H- PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM- 1-OLATE | A,B | 1Q9D | 0.71 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.73 | |
3QC | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.72 | |
L01 | 3-[({(1S,2R)-1-BENZYL-2-HYDROXY- 3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)(HYDROXY)METHYL]- N,N-DIPROPYLBENZAMIDE | A | 1W51 | 0.71 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AH8 | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1HCJ | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7S | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7T | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AHA | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EME | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 1KP5 | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EMM | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EML | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7U | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1EMC | 0.73 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 2HPW | 0.73 | |
CZO | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]- 2-hydroxy-4-(4-hydroxybenzyl)-5- oxoimidazolidin-1-yl]acetic acid | A | 2QRF | 0.73 | |
UBC | (S)-1-(2-AMINO-2-CARBOXYETHYL)- 3-(2-CARBOXYBENZYL)PYRIMIDINE-2,4- DIONE | A,B | 2F35 | 0.75 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.75 | |
IYR | 3-IODO-TYROSINE | A | 2D98 | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2D8P | 0.72 | |
IYR | 3-IODO-TYROSINE | A,B | 3GFD | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2R1Q | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2ZP1 | 0.72 | |
IYR | 3-IODO-TYROSINE | A,B,C,D | 2ZXV | 0.72 | |
IYR | 3-IODO-TYROSINE | C | 1CF0 | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 1XXZ | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2D97 | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 1XY9 | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2Z10 | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 1WQ3 | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2D8O | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2D8W | 0.72 | |
IYR | 3-IODO-TYROSINE | A | 2Z11 | 0.72 | |
UR2 | 4-[3-CARBOXYMETHYL-3-(4-PHOSPHONOOXY- BENZYL)-UREIDO]-4-[(3-CYCLOHEXYL- PROPYL)-METHYL-CARBAMOYL]BUTYRIC ACID | A | 1SKJ | 0.71 | |
MOY | [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN- 5-YL](PHENYL)METHANONE | A,B | 2IEH | 0.87 | |
247 | (3R)-3-amino-2,2-difluoro-3-(4- hydroxyphenyl)propanoic acid | A,B | 2QVE | 0.73 | |
TYB | TYROSINAL | A,B | 1KDZ | 0.74 | |
TYB | TYROSINAL | A | 1Q11 | 0.74 | |
TYB | TYROSINAL | A,B | 2J5B | 0.74 | |
TYB | TYROSINAL | A,I | 1GA4 | 0.74 | |
TYB | TYROSINAL | A,B,C | 1NLU | 0.74 | |
TYB | TYROSINAL | A,B | 1KE1 | 0.74 | |
TYB | TYROSINAL | A,B | 1H3F | 0.74 | |
TYB | TYROSINAL | A,B | 1H3E | 0.74 | |
D4P | (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A | 1DSR | 0.74 | |
D4P | (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H | 1W7R | 0.74 | |
D4P | (2S)-AMINO(4-HYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1W7Q | 0.74 | |
IFB | N-[(2',4'-DIFLUORO-4-HYDROXY-5- IODOBIPHENYL-3-YL)CARBONYL]-BETA- ALANINE | A,B | 3FCB | 0.71 | |
BFS | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A | 1STD | 0.74 | |
BFS | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A,B,C | 4STD | 0.74 | |
SGI | 3-(4-hydroxyphenyl)propanamide | A,B | 2R9K | 0.72 | |
VBP | 4-({3-[(2R)-2-amino-2-carboxyethyl]- 2,6-dioxo-3,6-dihydropyrimidin- 1(2H)-yl}methyl)benzoic acid | B,E,G,H,J,L, N,P | 3H06 | 0.76 | |
DTY | D-TYROSINE | A | 1C4B | 0.74 | |
DTY | D-TYROSINE | A,L | 1ZEA | 0.74 | |
DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.74 | |
DTY | D-TYROSINE | A,B | 1UNO | 0.74 | |
DTY | D-TYROSINE | A | 2IGZ | 0.74 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.74 | |
DTY | D-TYROSINE | A,B | 2Q33 | 0.74 | |
DTY | D-TYROSINE | H,S | 2H9E | 0.74 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.74 | |
DTY | D-TYROSINE | A | 2IH0 | 0.74 | |
DTY | D-TYROSINE | A | 1D7T | 0.74 | |
DTY | D-TYROSINE | A,B | 1XA0 | 0.74 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.71 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.71 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.71 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.76 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.76 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.76 | |
YBY | N-{[(1S)-1-carboxy-2-(4-hydroxy- 3-iodophenyl)ethyl]carbamoyl}-L- glutamic acid | A | 3D7F | 0.77 | |
HBZ | N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}- beta-D-glucopyranosylamine | A | 2QN7 | 0.71 | |
SD2 | N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE | A,B | 1PWQ | 0.7 | |
4BA | 4-[(2-CARBOXY-ETHYLAMINO)-METHYL]- BENZOIC ACID | C | 1FAV | 0.71 | |
FEN | N-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE | A | 1FEL | 0.7 | |
3FL | 3-{[(4-{[(2,6-dioxo-1,2,3,6-tetrahydropyrimidin- 4-yl)methyl]amino}butyl)amino]methyl}benzoic acid | A,B | 3FCL | 0.73 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 1L6M | 0.73 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 3CBC | 0.73 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 3BY0 | 0.73 | |
MN7 | 1-CARBOXY-4-ISOBUTYLAMINOMETHYLBENZENE | N | 1NLO | 0.71 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.75 | |
CTA | CYCLOTHEONAMIDE A | A | 1TYN | 0.73 | |
ECA | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3- DIHYDROXYBENZAMIDE) | A,B | 2CHU | 0.71 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.72 |